OBJECTIVE
People with Parkinson's disease (PD) who carry a pathogenic GBA1 variant (PDGBA1) are at higher risk of cognitive impairment than those without the variant (PDGBA1_wildtype). To date, little is known about the pattern and evolution of cognitive decline in PDGBA1. This multicenter study characterized the cogni...
Merle Bode, C. Pauly, S. Jónsdóttir et al.· Annals of Neurology· 0 citations
Amyloid and tau positivity in DLB were associated with worse global cognitive outcomes, but not with motor performance, and NfL levels were elevated across diseases, and total α‐synuclein levels were associated with tau positivity.
Marianna Rizzo, C. Teunissen, H. Zetterberg et al.· Alzheimer's & Dementia· 0 citations
Cognitive aging is shaped by genetic variation, environmental factors, and health-related conditions. Until now, it is largely unclear why some individuals maintain their cognitive function, and others show progressive cognitive decline. This study uncovered determinants of distinct cognitive aging trajectories in the...
L. Federmann, Christian Mychajliw, U. Suenkel et al.· GeroScience· 0 citations
CSF TIMP2 levels primarily reflect ageing-related processes associated with neurodegeneration rather than disease-specific effects, and support a role of extracellular matrix-related ageing mechanisms in PD and related disorders.
M. Zimmermann, Madeleine Fandrich, C. Schulte et al.· GeroScience· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.